CLINICAL_TRIALS
trial_result
· 2021-08-20
Clinical Trial Update: Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo [Phase 2]
Summary
Phase 2 trial comparing LY2140023, olanzapine, and placebo in schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED